-
Abstract Number: PB1248
U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPS Matter Study) Interim Analysis of the 2010-2019 Birth Cohort
-
Abstract Number: PB0947
UK EHL Registry: Patient Reported Outcomes Measured by Haemoprefer Patient Treatment Preference and Perception Tool
-
Abstract Number: PB0518
UK NEQAS for Blood Coagulation D-Dimer Point of Care Testing Programme: A Review of Data
-
Abstract Number: OC 08.1
Ultra High-throughput Screening Assay to Identify New Antiplatelet Drugs with Discriminative Mode of Receptor-dependent Action
-
Abstract Number: PB1100
Ultrasound Mediated Gene Delivery Targets Liver Sinusoidal Endothelial Cells to Achieve Endothelial-specific Factor VIII Expression
-
Abstract Number: PB0043
Un Untargeted Lipidomic Analysis Reveals Lactosylceramide as Mediator of Monocyte Migration in Coronary Artery Disease Patients
-
Abstract Number: PB1183
Uncharacterised bleeding Disorders Are Associated with Reduced Platelet and Microparticle Thrombin Generation and Decreased Procoagulant Oxidised Phosphatidylcholine
-
Abstract Number: PB1209
Unclassified Bleeding Disorder (UBD)-Bleeding Phenotype and Management
-
Abstract Number: PB1588
Uncommon Types of von Willebrand Disease
-
Abstract Number: PB2150
Uncovering Clinical Gaps in Treatment of Cancer-Associated Thrombosis: A Clinical Practice Assessment
-
Abstract Number: PB1426
Underlying Causes Greatly Influence the Development of HIT Antibodies and Clinical Outcomes in Patients with Heparin-induced Thrombocytopenia
-
Abstract Number: PB0820
Unexpected Phenotypic Characteristics Associated with Severe Haemophilia B in Two Paediatric Patients with Deletions Involving the Whole F9 and Contiguous Genes
-
Abstract Number: PB0681
Unique Ready to Use, Highly Stable Multiplatform Chromogenic Assays to Facilitate Laboratory Practice
-
Abstract Number: OC 01.3
Unraveling the Protective Effects of Factor Xa Inhibition by Rivaroxaban on Atherosclerosis by RNA Sequencing
-
Abstract Number: PB0680
Updated CLOTSref: A Mobile Application for Standardized Reference Ranges in Developmental Hemostasis
-
Abstract Number: PB2435
Upper Extremities Deep Vein Thrombosis and DOAC Treatment: a Prospective Cohort Study
-
Abstract Number: PB2249
Upregulation of Factor XI in End Stage Renal Disease Is Associated with Increased Thrombin Generation and D-dimer
-
Abstract Number: PB0442
Upregulation of Inflammatory Biomarkers in Pulmonary Embolism as Studied by a Biochip- Array Profiling Approach
-
Abstract Number: PB0832
Uptake of MyABDR in Australia
-
Abstract Number: PB1474
Uremia Induced Pre-Activation Results in Platelet Function Impairment in Chronic Kidney Disease
-
Abstract Number: PB1262
Use of ‘Virtual Clinics’ Telehealth Model in Pediatric Patients with Hemophilia and Inherited Bleeding Disorders: Experience from a Tertiary Care Center
-
Abstract Number: PB2117
Use of a Cancer Screening Tool as Part of a Conservative Approach to Screening for Occult Malignancy after Unprovoked DVT: The King’s College Hospital Experience
-
Abstract Number: PB1501
Use of a Whole Exome “Slice” for Evaluation of Inherited Platelet Disorders
-
Abstract Number: PB2132
Use of Anti-Factor Xa Levels in Cancer Patients Taking Direct Oral Anticoagulants
-
Abstract Number: PB1026
Use of Desmopressin in the Treatment of Bleeding in Non-severe Haemophilia A
-
Abstract Number: PB2098
Use of Direct Oral Anticoagulants (DOACs) as Primary or Secondary Prophylaxis of Venous Thromboembolism in Patients with Multiple Myeloma on Immunomodulatory Drugs
-
Abstract Number: PB2224
Use of Direct Oral Anticoagulants in Congenital Thrombophilias
-
Abstract Number: PB1332
Use of Eltrombopag in Children with Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
-
Abstract Number: PB0964
Use of Emicizumab Prophylaxis in Adult and Pediatric Hemophilia A Patients with and without Inhibitors: Single Center Experience
-
Abstract Number: PB0700
Use of Liquid Low Molecular Weight Heparin Anti-Xa Assay for Detection of Apixaban
-
Abstract Number: PB2500
Use of Oral Contraceptives (OCs) and Thrombin Generation: Cross-sectional Analysis of the Longitudinal Study of Adult Health (ELSA-Brazil)
-
Abstract Number: PB1265
Use of Prolong Parenteral Lipid Emulsions in NICU and Hematologic Disorders
-
Abstract Number: PB0301
Use of Prothrombin Complex Concentrate for Reversal of Oral Anticoagulants in the Clinical Practice of a Portuguese Tertiary Hospital
-
Abstract Number: PB0291
Use of Recombinant von Willebrand Factor Alone during Surgeries in Type 2 von Willebrand Patients: Case Reports
-
Abstract Number: PB1194
Use of the ISTH Bleeding Assessement Tool in Diagnosis of Bleeding Disorders in West Algeria
-
Abstract Number: PB0864
Use of Thromboelastography and Thrombin Generation Assay in a Patient Treated with Emicizumab
-
Abstract Number: PB0327
Use of Thromboelastography to Monitor Emicizumab in a Patient with Severe Haemophilia A without Inhibitor
-
Abstract Number: PB0456
Usefulness of D-dimers Levels Determination in the Prediction of Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Anticoagulant Therapy
-
Abstract Number: PB1489
Usefulness of ISTH-BAT in Clinical Assessment of Inherited Platelet Disorders: Experience of the Spanish National Project
-
Abstract Number: PB1172
Usefulness of Tissue Factor-Independent Coagulation Parameters for Monitoring FXI-Concentrate Replacement in Patients with FXI-Deficiency
-
Abstract Number: PB2092
Using Baseline Characteristics to Differentiate Atrial Fibrillation Prevalence and Incidence in Pulmonary Embolism
-
Abstract Number: PB2564
Utility of Fibrinogen Levels and Rotational Thrombo Elastometry (ROTEM) in Predicting Post Partum Hemorrhage
-
Abstract Number: PB0355
Utility of Prophylactic Fresh Frozen Plasma Transfusion for Correction of Coagulopathy Prior to Image-Guided Drainage for Infected Collections
-
Abstract Number: PB1499
Utility of the ISTH Bleeding Assessment Tool (BATs) in Diagnosis of Glanzmann Thrombasthenia Patients – Experience from Pakistan
-
Abstract Number: PB1497
Utility of the ISTH Bleeding Assessment Tool and the Pediatric Bleeding Questionnaire in predicting platelet function defects in pediatric patients with excessive bleeding
-
Abstract Number: PB1068
Utilizing Continuous Factor Infusion Replacement in a Hemophilia B Patient Undergoing Cardiac Surgery
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.